ARCHIVES

Memantine Can Delay Onset Of Cognitive Function Decline

This article is from The Cancer Letter archive.

Vol. 35 No. 11 | November 30, 2012

Download PDF Visit The Full Archive

Related Articles

Cell Therapeutics To Appeal FDA Decision on Pixantrone.

September 17, 2010

Irinotecan And Carboplatin Improve Response In NSCLC

June 24, 2005

Basic Research Group Seeks $7.9 Billion For NIH, $1.7 For NCI

July 24, 1987

CMS Considering Regulatory Standards for Drug Company Bundling of Products.

October 20, 2006

FDA Committee Okays Carboplatin For Second Line Ovarian Cancer

January 6, 1989

Viral Oncology Not Losing $5 Mil. This Year – But Watch Out for ‘79

January 6, 1978